{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:28:04Z","timestamp":1781641684164,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12015-025-11000-9","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:58:51Z","timestamp":1763132331000},"page":"657-667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of EASIX Score with Non-relapse Mortality and Overall Survival in Pediatric Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1007","volume":"22","author":[{"given":"Amir","family":"Kasaeian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Kiumarsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Khavandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hediyeh","family":"Alemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Ahangar-Sirous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Janbabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"8","key":"11000_CR1","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.bbmt.2018.03.002","volume":"24","author":"I Yaniv","year":"2018","unstructured":"Yaniv, I., et al. (2018). Second hematopoietic stem cell transplantation for post-transplantation relapsed acute leukemia in children: A retrospective EBMT-PDWP study. Biology of Blood and Marrow Transplantation, 24(8), 1629\u20131642.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"11000_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ajh.25661","volume":"95","author":"A P\u00e9rez-Mart\u00ednez","year":"2020","unstructured":"P\u00e9rez-Mart\u00ednez, A., et al. (2020). Haploidentical transplantation in high\u2010risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working group for bone marrow transplantation in children (GETMON) and the Spanish grupo for hematopoietic transplantation (GETH). American Journal of Hematology, 95(1), 28\u201337.","journal-title":"American Journal of Hematology"},{"issue":"11","key":"11000_CR3","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41409-018-0171-z","volume":"53","author":"M Horowitz","year":"2018","unstructured":"Horowitz, M., et al. (2018). Epidemiology and biology of relapse after stem cell transplantation. Bone Marrow Transplantation, 53(11), 1379\u20131389.","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"11000_CR4","doi-asserted-by":"publisher","first-page":"e007635","DOI":"10.1136\/jitc-2023-007635","volume":"12","author":"O Penack","year":"2024","unstructured":"Penack, O., et al. (2024). Endothelial activation and stress index (EASIX) to predict mortality after allogeneic stem cell transplantation: A prospective study. Journal for ImmunoTherapy of Cancer, 12(1), e007635.","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"2","key":"11000_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2018","unstructured":"Corbacioglu, S., et al. (2018). Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: A new classification from the European society for blood and marrow transplantation. Bone Marrow Transplantation, 53(2), 138\u2013145.","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"11000_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41409-019-0703-1","volume":"55","author":"T Luft","year":"2020","unstructured":"Luft, T., et al. (2020). EASIX and mortality after allogeneic stem cell transplantation. Bone Marrow Transplantation, 55(3), 553\u2013561.","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"11000_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jtct.2021.04.025","volume":"27","author":"M Hotta","year":"2021","unstructured":"Hotta, M., et al. (2021). Elevation of early plasma biomarkers in patients with clinical risk factors predicts increased nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. Transplantation and Cellular Therapy, 27(8), 660. e8.","journal-title":"Transplantation and Cellular Therapy"},{"key":"11000_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01446","volume":"8","author":"RE Crossland","year":"2017","unstructured":"Crossland, R. E., et al. (2017). Serum and extracellular vesicle microRNAs miR-423, miR-199, and miR-93* as biomarkers for acute graft-versus-host disease. Frontiers in Immunology, 8, Article 1446.","journal-title":"Frontiers in Immunology"},{"issue":"22","key":"11000_CR9","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1182\/bloodadvances.2018020214","volume":"2","author":"JL Ferrara","year":"2018","unstructured":"Ferrara, J. L., & Chaudhry, M. S. (2018). GVHD: Biology matters. Blood Advances, 2(22), 3411\u20133417.","journal-title":"Blood Advances"},{"issue":"18","key":"11000_CR10","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1182\/bloodadvances.2022008617","volume":"7","author":"L Kordelas","year":"2023","unstructured":"Kordelas, L., et al. (2023). EASIX-1year and late mortality after allogeneic stem cell transplantation. Blood Advances, 7(18), 5374\u20135381.","journal-title":"Blood Advances"},{"issue":"22","key":"11000_CR11","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1182\/bloodadvances.2022007381","volume":"6","author":"MT Nawas","year":"2022","unstructured":"Nawas, M. T., et al. (2022). Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Advances, 6(22), 5898\u20135907.","journal-title":"Blood Advances"},{"issue":"3","key":"11000_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41409-024-02489-8","volume":"60","author":"E Muratore","year":"2025","unstructured":"Muratore, E., et al. (2025). The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation, 60(3), 346\u2013352.","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"11000_CR13","doi-asserted-by":"publisher","first-page":"187e1","DOI":"10.1016\/j.jtct.2023.11.016","volume":"30","author":"A Pedraza","year":"2024","unstructured":"Pedraza, A., et al. (2024). Easix score correlates with endothelial dysfunction biomarkers and predicts risk of acute graft-versus-host disease after allogeneic transplantation. Transplantation and Cellular Therapy, 30(2), 187e1\u2013187e12.","journal-title":"Transplantation and Cellular Therapy"},{"issue":"1","key":"11000_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"A.C. Harris","year":"2016","unstructured":"Harris, A.C., et al. (2016). International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biology of Blood and Marrow Transplantation, 22(1), 4\u201310. https:\/\/doi.org\/10.1016\/j.bbmt.2015.09.001","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"282","key":"11000_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal Of The American Statistical Association, 53(282), 457\u2013481.","journal-title":"Journal Of The American Statistical Association"},{"key":"11000_CR16","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951","author":"RJ Gray","year":"1988","unstructured":"Gray, R. J. (1988). A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of statistics. https:\/\/doi.org\/10.1214\/aos\/1176350951","journal-title":"The Annals of statistics"},{"issue":"446","key":"11000_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P., & Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496\u2013509.","journal-title":"Journal of the American Statistical Association"},{"issue":"2","key":"11000_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"CR David","year":"1972","unstructured":"David, C. R. (1972). Regression models and life tables (with discussion). Journal of the Royal Statistical Society, 34(2), 187\u2013220.","journal-title":"Journal of the Royal Statistical Society"},{"key":"11000_CR19","unstructured":"R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna.\u00a0URL https:\/\/www.R-project.org\/"},{"issue":"10","key":"11000_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"P Rajendran","year":"2013","unstructured":"Rajendran, P., et al. (2013). The vascular endothelium and human diseases. International Journal of Biological Sciences, 9(10), 1057.","journal-title":"International Journal of Biological Sciences"},{"issue":"10","key":"11000_CR21","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/s41409-021-01390-y","volume":"56","author":"T Luft","year":"2021","unstructured":"Luft, T., Dreger, P., & Radujkovic, A. (2021). Endothelial cell dysfunction: A key determinant for the outcome of allogeneic stem cell transplantation. Bone Marrow Transplantation, 56(10), 2326\u20132335.","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"11000_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbmt.2009.01.013","volume":"15","author":"M Palomo","year":"2009","unstructured":"Palomo, M., et al. (2009). The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. Biology of Blood and Marrow Transplantation, 15(5), 537\u2013546.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"11000_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030623","volume":"11","author":"G Milone","year":"2022","unstructured":"Milone, G., et al. (2022). Endothelial dysfunction after hematopoietic stem cell transplantation: A review based on physiopathology. Journal of Clinical Medicine, 11(3), Article 623.","journal-title":"Journal of Clinical Medicine"},{"issue":"7","key":"11000_CR24","doi-asserted-by":"publisher","first-page":"356e1","DOI":"10.1016\/j.jtct.2022.05.001","volume":"28","author":"UP Kulkarni","year":"2022","unstructured":"Kulkarni, U. P., et al. (2022). Endothelial activation and stress index-measured pretransplantation predicts transplantation-related mortality in patients with thalassemia major undergoing transplantation with Thiotepa, Treosulfan, and fludarabine conditioning. Transplantation and Cellular Therapy, 28(7), 356e1\u2013356e6.","journal-title":"Transplantation and Cellular Therapy"},{"issue":"17","key":"11000_CR25","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1182\/bloodadvances.2021004812","volume":"5","author":"M Pe\u00f1a","year":"2021","unstructured":"Pe\u00f1a, M., et al. (2021). Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. Blood Advances, 5(17), 3418\u20133426.","journal-title":"Blood Advances"},{"issue":"2","key":"11000_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/bmt.2013.151","volume":"49","author":"J Kanda","year":"2014","unstructured":"Kanda, J., et al. (2014). Risk factors and organ involvement of chronic GVHD in Japan. Bone Marrow Transplantation, 49(2), 228\u2013235.","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"11000_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/bmt.2016.328","volume":"52","author":"B Watkins","year":"2017","unstructured":"Watkins, B., et al. (2017). Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant. Bone Marrow Transplantation, 52(4), 625\u2013626.","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"11000_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/bjh.16182","volume":"188","author":"A Bazarbachi","year":"2020","unstructured":"Bazarbachi, A., et al. (2020). Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma\u2013a LWP-EBMT study. British Journal of Haematology, 188(5), 745\u2013756.","journal-title":"British Journal of Haematology"},{"issue":"20","key":"11000_CR29","first-page":"3193","volume":"125","author":"H Nakasone","year":"2015","unstructured":"Nakasone, H., et al. (2015). Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans. Blood. The Journal of the American Society of Hematology, 125(20), 3193\u20133201.","journal-title":"The Journal of the American Society of Hematology"},{"issue":"11","key":"11000_CR30","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3324\/haematol.2015.125294","volume":"100","author":"H Nakasone","year":"2015","unstructured":"Nakasone, H., et al. (2015). Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy. Haematologica, 100(11), 1477.","journal-title":"Haematologica"},{"issue":"2","key":"11000_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jcyt.2024.09.007","volume":"27","author":"M Tamaki","year":"2025","unstructured":"Tamaki, M., et al. (2025). Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation. Cytotherapy, 27(2), 213\u2013221.","journal-title":"Cytotherapy"},{"issue":"5","key":"11000_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41409-023-01922-8","volume":"58","author":"M Sanchez-Escamilla","year":"2023","unstructured":"Sanchez-Escamilla, M., et al. (2023). EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 58(5), 498\u2013505.","journal-title":"Bone Marrow Transplantation"},{"issue":"9","key":"11000_CR33","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/S2352-3026(17)30108-4","volume":"4","author":"T Luft","year":"2017","unstructured":"Luft, T., et al. (2017). EASIX in patients with acute graft-versus-host disease: A retrospective cohort analysis. The Lancet Haematology, 4(9), e414\u2013e423.","journal-title":"The Lancet Haematology"},{"issue":"3","key":"11000_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41409-022-01874-5","volume":"58","author":"J Mariotti","year":"2023","unstructured":"Mariotti, J., et al. (2023). EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transplantation, 58(3), 247\u2013256.","journal-title":"Bone Marrow Transplantation"},{"key":"11000_CR35","unstructured":"Jagasia, M.H., et al. (2015). National Institutes of Health consensus development project on\u00a0criteria for clinical trialsin chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biology of blood and marrow transplantation, 21(3), 389\u2013401. e1.\u00a0"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-11000-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11000-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:06:12Z","timestamp":1768341972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-11000-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["11000"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-11000-9","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Committee on Medical Ethics of RIOHCT, TUMS, Tehran, Iran (Code: IR.TUMS.HORCSCT.REC.1402.065). The study adhered to the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Consent for publication was given by parents or legal guardians of the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Parents or legal guardians of all patients provided written informed consent to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent To Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}